Eli Lilly and Co. (LLY) - Get Eli Lilly and Company Report is expected to report net income of $1.3 billion, or $1.40 a share, on sales of $5.5 billion before the market opens on Wednesday, based on a FactSet survey of 10 analysts.
In the same period a year ago, the company posted earnings of $1.39 a share on sales of $6.1 billion. It reported a loss of 231.6 million.
The stock has fallen 0.7% since the company last reported earnings on July 30.
Quarterly estimates have fallen less than 1 cent a share in the past month.
In the upcoming quarter, analysts are forecasting net income of $1.4 billion, or $1.48 a share, on sales of $6 billion.
Eli Lilly is currently trading at a price-to-forward-earnings ratio of 17.1 based on the 12-month estimates of 12 analysts surveyed by FactSet.
Save 57% during our Halloween Sale. Don't let this market haunt you. Join Jim Cramer's Investment Club, Action Alerts PLUS. Click here to sign up!
Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.